AMLX EBITDA Growth
Amylyx Pharmaceuticals Inc · EBITDA Growth
AMLX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported20.14%period ending
AMLX TTM EBITDA YoY % (-175.96% → 20.14%)
Year-over-year change
High-resolution chart · PNG
AMLX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 20.1411% | |
| 32.4777% | |
| 52.7713% | |
| 41.7628% | |
| -16.3231% | |
| -239.3636% | |
| -643.8873% | |
| -3,947.4719% | |
| -131.1192% | |
| 56.4002% | |
| 128.098% | |
| 103.6323% | |
| 54.3755% | |
| -22.1485% | |
| -128.6069% | |
| -175.9625% |